Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IRON CLAD: Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Multi-center, Randomized, Double-blinded, Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose Injection) in Adults

NCT02453334 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT02453334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02453334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IRON CLAD: Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Multi-center, Randomized, Double-blinded, Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose Injection) in Adults
Lead sponsor
American Regent, Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 23, 2015
Completion date
January 4, 2018
Enrollment
244 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

cancer and chemotherapy related anemia